{"id":"NCT00408421","sponsor":"Eli Lilly and Company","briefTitle":"Duloxetine Versus Placebo for Osteoarthritis Knee Pain","officialTitle":"Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2007-10","completion":"2007-10","firstPosted":"2006-12-07","resultsPosted":"2009-08-19","lastUpdate":"2009-08-19"},"enrollment":231,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis Knee Pain"],"interventions":[{"type":"DRUG","name":"Duloxetine","otherNames":["LY248686","Cymbalta"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with osteoarthritis knee pain.","primaryOutcome":{"measure":"Weekly Change From Baseline in the 24-Hour Average Pain Rating Using an 11-Point Numerical Likert Scale Patient Diary","timeFrame":"Over 13 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":-0.36,"sd":0.15},{"arm":"Duloxetine 60mg /120mg","deltaMin":-0.84,"sd":0.16}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":27,"countries":["United States","Puerto Rico","Romania"]},"refs":{"pmids":["31505082","24650448","22133624"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2},"commonTop":["Nausea","Diarrhoea","Fatigue","Dizziness","Somnolence"]}}